BRINK BIOLOGICS

Brink Biologics, Inc. (BBI) is a ImmunityBio, Inc. (NASDAQ: IBRX) affiliated biotechnology solutions company located in the prestigious Torrey Pines biotechnology science park in San Diego, CA... Brink Biologics, Inc. holds the exclusive non-clinical rights to the NK-92®️ cell line and its CD16 expressing derivatives, all of which are uniquely and ideally suited for antibody-dependent cell-mediated cytotoxicity (ADCC) assays... The exclusive global provider of THE NK-92® cell line (AND ITS VARIANTS) AND THE NEUKOPANEL™ testing services, NEUKOPANEL™ CELL PANELS, and sublicenses within the life sciences and device industry.

Also known as: Brink Biologics, Inc.

Primary location: San Diego United States